APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SEVEN EIGHT CAPITAL, LP | 22,188 | $844,032 | 0.10% |
| Simplicity Solutions, LLC | 78,380 | $2,981,575 | 0.10% |
| J. Goldman & Co LP | 67,500 | $2,567,700 | 0.09% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 181,324 | $6,897,565 | 0.09% |
| Virtu Financial LLC | 23,235 | $884 | 0.09% |
| Candriam S.C.A. | 326,507 | $12,420,326 | 0.09% |
| XTX Topco Ltd | 12,796 | $486,760 | 0.08% |
| PICTON MAHONEY ASSET MANAGEMENT | 69,077 | $2,627 | 0.08% |
| LMR Partners LLP | 182,100 | $6,927,084 | 0.08% |
| SG Americas Securities, LLC | 174,569 | $6,641 | 0.08% |
| Virtus ETF Advisers LLC | 3,301 | $125,570 | 0.08% |
| PROFUND ADVISORS LLC | 35,153 | $1,337,220 | 0.07% |
| FOX RUN MANAGEMENT, L.L.C. | 6,433 | $244,711 | 0.07% |
| Orbimed Advisors | 77,500 | $2,948,100 | 0.06% |
| MACQUARIE GROUP LTD | 1,076,548 | $40,952,000 | 0.05% |
| Portman Square Capital LLP | 52,900 | $2,012,316 | 0.05% |
| CLEAR STREET MARKETS LLC | 12,500 | $476 | 0.05% |
| Rafferty Asset Management, LLC | 214,161 | $8,146,684 | 0.05% |
| Aquatic Capital Management LLC | 29,800 | $1,134 | 0.05% |
| BANQUE PICTET & CIE SA | 102,242 | $3,889,286 | 0.05% |
External links
This page lists APELLIS PHARMACEUTICALS INC's shareholders in Q3 2023. To view APELLIS PHARMACEUTICALS INC's shareholder history, click here.